References
- Allan B T, Patton D, Ramsey N KC. Pulmonary fungal infections after bone marrow transplantation. Pediatr Radiol. 1988; 18: 118–122
- Coleman J M, Hogg G G, Rosenfeld J V, Waters K D. Invasive central nervous system aspergillosis: cure with liposomal amphotericin-B, itraconazole, and radical surgery—case report and review of the literature. Neurosurgery 1995; 36: 858–863
- Dayan A D, Working P K. Non-clinical studies of the efficacy, pharmacokinetics and safety of amphotericin B colloidal dispersion. Amphotericin B Colloidal Dispersion (ABCD) in the Treatment of Disseminated Fungal Infections, DWR Mackenzie. Royal Society of Medicine Services, London 1996
- Williams M A, Kelsey S M, Collins P W. Administration of recombinant human granulocyte macrophage colony stimulating factor activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high dose chemotherapy. Br J Haematol. 1995; 90: 31–35
- Meunnier F. Overview of the treatment of disseminated fungal infections. Amphotericin B Colloidal Dispersion (ABCD) in the Treatment of Disseminated Fungal Infections, DWR Mackenzie. Royal Society of Medicine Services, London 1996
- Hazel D R, Smith J A, Newland A C, Kelsey S M. G-CSF increases the efficacy of conventional amphotericin B in the treatment of resumed deep seated fungal infection in neutropenic patients. American Society of Hematology 38th Annual Meeting and Exposition, Orlando, Florida, 6–10 December, 1996